Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,868 | 399 | 99.1% |
| Education | $56.99 | 1 | 0.7% |
| Consulting Fee | $14.99 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,058 | 115 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $946.72 | 51 | $0 (2024) |
| Janssen Biotech, Inc. | $590.07 | 25 | $0 (2024) |
| Gilead Sciences, Inc. | $504.35 | 20 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $362.00 | 20 | $0 (2024) |
| PFIZER INC. | $316.81 | 19 | $0 (2024) |
| Allergan, Inc. | $303.78 | 19 | $0 (2020) |
| Covidien LP | $241.87 | 3 | $0 (2017) |
| Ironwood Pharmaceuticals, Inc | $237.62 | 14 | $0 (2023) |
| Boston Scientific Corporation | $229.16 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,236 | 51 | ABBVIE INC. ($451.33) |
| 2023 | $1,478 | 73 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($410.88) |
| 2022 | $1,241 | 57 | ABBVIE INC. ($522.54) |
| 2021 | $689.38 | 36 | AbbVie Inc. ($165.11) |
| 2020 | $382.26 | 22 | PFIZER INC. ($69.94) |
| 2019 | $904.34 | 52 | AbbVie, Inc. ($159.34) |
| 2018 | $809.95 | 52 | AbbVie, Inc. ($204.82) |
| 2017 | $1,199 | 58 | Covidien LP ($241.87) |
All Payment Transactions
401 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/09/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Food and Beverage | In-kind items and services | $127.62 | General |
| Category: Immunology | ||||||
| 11/15/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: IMMUNOLOGY | ||||||
| 10/31/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.37 | General |
| Category: LIVER DISEASE | ||||||
| 10/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $6.60 | General |
| Category: VIROLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: VIROLOGY | ||||||
| 10/01/2024 | Boston Scientific Corporation | EXALT Model D (Device) | Food and Beverage | In-kind items and services | $38.97 | General |
| Category: EXALT Model D_ENDO | ||||||
| 09/25/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: IMMUNOLOGY | ||||||
| 09/04/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $26.40 | General |
| Category: IMMUNOLOGY | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/16/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $15.26 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $5.11 | General |
| Category: VIROLOGY | ||||||
| 08/08/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: VIROLOGY | ||||||
| 08/07/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: IMMUNOLOGY | ||||||
| 07/26/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Immunology | ||||||
| 07/23/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $34.21 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/19/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $0.43 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/12/2024 | Organon Llc | RENFLEXIS (Drug), HADLIMA | Food and Beverage | In-kind items and services | $20.04 | General |
| Category: INFLIXIMAB | ||||||
| 06/26/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $23.75 | General |
| Category: IMMUNOLOGY | ||||||
| 06/18/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $37.57 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 744 | 890 | $514,435 | $91,793 |
| 2022 | 15 | 808 | 958 | $542,326 | $95,769 |
| 2021 | 15 | 1,084 | 1,320 | $677,134 | $128,430 |
| 2020 | 19 | 1,175 | 1,587 | $676,915 | $138,766 |
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 145 | 150 | $141,450 | $29,904 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 159 | 206 | $80,752 | $17,879 | 22.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 75 | 155 | $32,550 | $9,336 | 28.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 76 | 76 | $60,268 | $7,837 | 13.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 95 | 98 | $58,800 | $6,717 | 11.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 36 | 46 | $71,576 | $5,306 | 7.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 30 | 30 | $22,410 | $5,113 | 22.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 39 | 39 | $15,600 | $3,866 | 24.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 63 | $17,388 | $3,270 | 18.8% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 11 | 11 | $8,217 | $1,694 | 20.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $5,424 | $872.08 | 16.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 139 | 141 | $132,963 | $27,186 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 163 | 221 | $86,632 | $18,518 | 21.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 76 | 155 | $32,550 | $8,442 | 25.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 96 | 100 | $60,000 | $6,828 | 11.4% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2022 | 38 | 38 | $28,386 | $6,619 | 23.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 74 | 74 | $58,682 | $5,836 | 9.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 44 | 44 | $17,600 | $4,465 | 25.4% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2022 | 32 | 35 | $54,460 | $4,313 | 7.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 60 | $16,560 | $3,221 | 19.5% |
| 43259 | Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $16,305 | $2,549 | 15.6% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 13 | 13 | $9,711 | $2,306 | 23.7% |
| 43242 | Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 11 | 11 | $10,340 | $1,817 | 17.6% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $8,160 | $1,778 | 21.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 14 | $4,214 | $1,091 | 25.9% |
About Dr. Steven Carpenter, MD
Dr. Steven Carpenter, MD is a Gastroenterology healthcare provider based in Savannah, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952386898.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Carpenter, MD has received a total of $7,940 in payments from pharmaceutical and medical device companies, with $1,236 received in 2024. These payments were reported across 401 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($7,868).
As a Medicare-enrolled provider, Carpenter has provided services to 3,811 Medicare beneficiaries, totaling 4,755 services with total Medicare billing of $454,758. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Savannah, GA
- Active Since 12/14/2005
- Last Updated 02/13/2015
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1952386898
Products in Payments
- XIFAXAN (Drug) $653.61
- RINVOQ (Biological) $552.53
- STELARA (Biological) $450.51
- LINZESS (Drug) $312.89
- XELJANZ (Drug) $286.82
- Humira (Biological) $267.36
- HUMIRA (Biological) $231.34
- SKYRIZI (Biological) $227.41
- VIBERZI (Drug) $208.79
- Linzess (Drug) $177.20
- ENTYVIO (Biological) $170.64
- DUPIXENT (Biological) $170.54
- TRULANCE (Drug) $168.82
- Vemlidy (Drug) $156.79
- VOQUEZNA (Drug) $151.20
- Barrx (Device) $150.05
- DIFICID (Drug) $149.60
- MAVYRET (Drug) $147.78
- TREMFYA (Drug) $142.05
- TheraSphere Y90 Glass Microspheres 10 GBq (Device) $139.90
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Savannah
Dr. Daniel Mullady, Md, MD
Gastroenterology — Payments: $119,628
George Aragon, Md, MD
Gastroenterology — Payments: $17,588
Travis Wiggins, M.d, M.D
Gastroenterology — Payments: $17,255
Dr. John Northup, M.d, M.D
Gastroenterology — Payments: $14,252
Ryan Wanamaker, Md, MD
Gastroenterology — Payments: $13,508
Mark Nyce, Md, MD
Gastroenterology — Payments: $10,771